Concepedia

Ria Wouters

RW

6

Publications

458

Citations

6

H-Index

1996

Active since

Affiliations

Janssen (Belgium)(Current)

Johnson & Johnson (United States)

Ria Wouters is an author at Janssen (Belgium) specializing in pharmacotherapy, medicine, and drug discovery.

Top concepts

Publications per year

1996–2012

6

Publications

6

JNJ16259685, a highly potent, selective and systemically active mGlu1 receptor antagonist

Hilde Lavreysen, Ria Wouters, François Bischoff et al. · Neuropharmacology · 2004 · 138 citations

, , +9

Synthesis, Structure−Activity Relationship, and Receptor Pharmacology of a New Series of Quinoline Derivatives Acting as Selective, Noncompetitive mGlu1 Antagonists

Dominique Mabire, Sophie Coupa, Christophe Adelinet et al. · Journal of Medicinal Chemistry · 2005 · 96 citations · Full text

, , +15

Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.

J.E. Leysen, W Gommeren, Lieve Heylen et al. · Molecular Pharmacology · 1996 · 91 citations

Synthesis and Biological Activities of Conformationally Restricted Cyclopentenyl-Glutamate Analogues

Alison T. Ung, Karl Schafer, Karl B. Lindsay et al. · The Journal of Organic Chemistry · 2001 · 47 citations

Pharmacology of JNJ-37822681, a Specific and Fast-Dissociating D2 Antagonist for the Treatment of Schizophrenia

Xavier Langlois, Anton A. H. P. Megens, Hilde Lavreysen et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 45 citations

Rows per page

1–5 of 6